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Summary 
Mice rendered deficient in the production of interleukin  10 (IL-10  -/-)  develop a chronic in- 
flammatory bowel  disease  (IBD)  that predominates  in the  colon and  shares histopathological 
features  with human IBD. Our aim was to identify which cell type(s)  can mediate  colitis in 
IL-10  -/- mice. We detected an influx ofimmunoglobulin-positive cells into the colon and the 
presence of colon-reactive antibodies in the serum of IL-10  -/- mice. To assess a pathogenic role 
for B cells,  we generated a B cell-deficient (B -/-) strain oflL-10 -/- mice. B-/-IL-10  -/- mice 
acquired a severe colitis analogous to that oflL-10 -/- mice, implying that B cells were not the 
primary mediator of IBD in this model. A  series of cell transfer experiments was performed to 
assess a pathogenic role for T  cells.  When IL-10  -/-  T  cell-enriched lamina propria lympho- 
cytes (LPL) or intraepithelial lymphocytes (IEL) were transferred into immunodeficient recom- 
binase-activating gene (RAG)-2 -/- recipients,  a mild to severe colitis developed, depending on 
the cell number transferred. Lymphocytes recovered from the colon of transplanted R.AG-2 -/- 
mice  with  colitis  were  predominantly  otI~TCR+CD4 +,  including  a  large  proportion  of 
CD4§  +  cells.  These  cells  were  also  CD45RB -/l~  and  CD44 +,  indicative  of an  acti- 
vated/memory  population.  Individual  populations  of  CD4+CD80~ -,  CD4+CD8oe +  and 
CD4-CD8ot +  T  cells  were  then isolated from the  lamina propria  compartment  of IL-10  -/- 
mice and transferred into RAG-2 -/- recipients. Only IL-10  -/- CD4-expressing LPL, including 
both the CD4+CD8ot -  and CD4+CD8r  + populations,  induced colitis in recipient mice.  In- 
terferon-',/,  but little  to no IL-4, was produced by CD4+CD8o~ -  and CD4+CD8ot §  LPL re- 
covered  from  the  inflamed  colons  of RAG-2  -/-  recipients  implicating  a  T  helper  cell  1 
(TH1)-mediated  response.  We thus conclude that colitis in IL-10  -/-  mice is predominantly 
mediated by THl-type cll3TCtk + T  cells expressing CD4 alone,  or in combination with the 
CD8ct molecule. 
H 
'uman inflammatory bowel  disease  (IBD) 1 is  divided 
.into two major categories, ulcerative colitis and Crohn's 
disease  (1-3).  Both  diseases  exhibit  a  characteristic  profile 
of chronic  inflammation,  the  former  involving  the  large 
bowel, particularly the distal colon and rectum, and the lat- 
ter  including  small  bowel  inflammation.  Whereas  little  is 
known  regarding  the  etiology  of these  disorders,  IBD  is 
thought to be amplified or perpetuated as a result of an un- 
controlled  immune  response  to  enteric  antigens,  presum- 
ably bacterial in origin (4,  5). 
1Abbreviations used in this paper: AMCA, aminomethylcoumarin acetate; 
B -/-, B cell-deficient mice; H & E, hematoxylin and eosin; IBD, inflam- 
matory bowel disease; IEL, intraepithelial lymphocyte(s);  IL-10  -/-, IL-10- 
deficient mice; LPL, lamina propria lymphocyte(s);  RAG-2  -/-, recombi- 
nase-activating gene 2-deficient mice; SAA, serum amyloid A; WT, wild 
type (IL-10+/+). 
Both the humoral and cell-mediated  components of the 
immune  system have been  implicated  in the  pathogenesis 
of human IBD and, more recently, routine models of IBD. 
Abs reactive with enteric flora such as Campytobacterjejuni, 
which also react with gut tissue and peripheral blood com- 
ponents,  have been identified  in human patients,  particu- 
larly those with ulcerative  colitis  (1-3,  6,  7).  An IgG1 Ab 
reactive with colonic epithelial cells has been described that 
can be found colocalized with activated complement com- 
ponents  in  tissue  sections  of  human  colon  implicating 
autoAb  in  tissue  damage  (8,  9).  A  pathogenic  role  for B 
cells and Abs has also been suggested by routine models of 
IBD. Anticolon Abs have been detected  in  IL-2  -/-  mice 
(10).  IBD in TCR  and MHC  mutant mice,  which are al- 
most devoid of mature CD4 + T  cells, is postulated to result 
from a lack of T  cell-mediated  suppression  of B  cells  and 
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pathogenic role for T  cells has been  suggested by the  in- 
creased  frequency  of highly  activated  T  cells  present  in 
both gut tissues and peripheral blood oflBD patients (1-3). 
Furthermore,  increased serum levels of IL-2 receptor and 
enhanced production  of IFN-~/ and  TNF-Ix by mononu- 
clear cells isolated from the gut correlate well with disease 
activity (1-3). IBD can also be induced in immunodeficient 
mice  by reconstitution  with  peripheral T  cells transgenic 
for  the  human  CD3e  molecule  (12)  or  normal  CD45- 
R_BhiCD4+  splenic T  cells (13,  14).  Additionally, indirect 
evidence  that  T  cells can mediate  colitis in  IL-2  -/-  mice 
has been recently reported (15). Together, these data strongly 
support  the  hypothesis  that  B  and/or  T  cells,  and  their 
products, are key mediators in certain types of human and 
murine IBD. 
IBD,  resembling  Crohn's  disease in  humans,  is  a  pre- 
dominant feature of mice with a targeted disruption of the 
IL-10 gene  (IL-10-/-;  16,  17,  18).  IL-10 is normally pro- 
duced by a variety of cell types, including lymphocytes and 
macrophages, and whereas it displays a broad range of ac- 
tivities,  one  of its  major  roles  is  that  of suppressing  cell- 
mediated  immune  and  inflammatory  responses  (19,  20). 
Therefore, it has been proposed that IBD develops in spe- 
cific pathogen-free IL-10  -/-  mice as a result of an uncon- 
trolled immune  response to normal  enteric flora, and  thus 
IL-10 is essential in regulating mucosal immunity  (16-18). 
Whether  an  aberrant response to  enteric flora is primarily 
mediated by T  and/or B  tymphocytes has not yet been elu- 
cidated. An extensive mononuclear cell infiltrate is present in 
the mucosa and submucosa of the colon and cecum of IL- 
10 -/-  mice  with  colitis  (16-18).  Many  of these  cells are 
plasma cells and elevated levels of IgA or IgG1  can be de- 
tected in the serum of IL-10  -/-  mice (16). The cells com- 
prising the inflammatory infiltrate also include a high inci- 
dence  of  phenotypically  activated/memory  CD4+CD8oL - 
and CD4+CD8c~ + ci[3TCtL + T  cells (17,  18). Furthermore, 
CD4 §  T  lymphocytes  isolated from  these  mice  produce 
high levels of IFN-% but not IL-4, implicating a TH1  re- 
sponse in the pathogenesis oflBD in IL-10  -/-  mice. Hence, 
we employed the IL-10  -/- mice model of colitis to ascertain 
the respective roles of B  and T  cells in mediating IBD. 
Materials  and Methods 
Mice.  IL-10 -/- mice generated by targeted gene  disruption 
on a C57BL/6/129-Ola background and wild-type (WT) litter- 
mate controls were provided by W. Mfiller. IL-10  -/- mice and 
WT littermates bred onto a  129/SvEv background were kindly 
provided by Dr.  R.  Coffman  (DNAX).  B  cell-deficient mice 
(t3 -/-) generated on a C57BL/6/129/Sv background by targeted 
disruption of the membrane exon of  the Ig Ix chain gene (21) were 
kindly provided by Dr. A. O'Garra (DNAX). B -/- IL-10  -/- mice 
were generated at DNAX. All mouse strains were derived by ce- 
sarean section under specific pathogen-free conditions at Simon- 
sen  Laboratories (Gilroy, CA)  and  maintained in  microisolator 
cages in the Animal Care Facility of the DNAX Research Institute. 
Immunodeficient 129/SvEv recombinase-activating gene 2-deft- 
cient (RAG-2  -/-) mice were obtained from Taconic Farms, Inc. 
(Germantown, NY) and maintained at DNAX as described above. 
Abs.  All mAbs were diluted in PBS containing 1% (vol/vol) 
heat-inactivated FCS (PBS/FCS). For cell sorting, anti-mouse CD4 
conjugated to FITC (clone RM4-5,  10  I~g/ml) and PE-conju- 
gated anti-CD8ot (clone 53.67, 4 Ixg/ml; both from PharMingen, 
San Diego, CA) were used. The following mAbs were used for 
flow cytometric analysis: Tri-ColorVM-conjugated anti-mouse CD4 
(clone  YTS  191.1,  2  ~g/ml;  Caltag  Laboratories,  South  San 
Francisco,  CA);  anti-CD8cl-PE;  anti-CD3-FITC  (clone  145- 
2Cll, 5 Ixg/ml); anti-cl[3TCR-PE (clone H57-597, 1 I.Lg/ml);  anti- 
~/STCR-FITC  (clone  GL-3,  5  Ixg/m_l); anti-CD45RB-FITC 
(clone 16A, 5 Ixg/ml); and anti-CD44-PE (clone IM7, I  ~g/ml; 
all from PharMingen). Isotype controls included rat IgG2a-FITC 
(Caltag), rat IgG2a-PE (PharMingen), and rat IgG2b-Tri-Color  TM 
(PharMingen).  Immunohistochemistry  employed the  following 
mAbs:  purified,  unconjugated  anti-CD4  (clone  YTS  191.t,  4 
Ixg/ml; Caltag); purified, unconjugated anti-CDSo~  (clone 53.67, 
4  Ixg/ml; PharMingen); donkey anti-mouse IgG (H+L)  conju- 
gated to aminomethylcoumarin acetate (AMCA; 30/~g/ml; Jack- 
son ImmunoResearch Laboratories Inc., West Grove, PA); rabbit 
anti-bovine cytokeratin (broad spectrum anti-sera,  1:100  dilu- 
tion; Dakopatts,  Santa Barbara,  CA); goat anti-rat IgG (~/+L)- 
FITC  (8  I-tg/ml; Caltag); rhodamine  isothiocyanate-conjugated 
goat anti-rabbit IgM and IgG (H+L, 25  Ixg/ml); and goat anti- 
mouse lgG (~/-specific;  10 I.tg/ml; both from Southern Biotech- 
nology Associates Inc., Birmingham, AL). 
Peripheral Blood Analysis.  Blood samples were obtained from 
RAG-2  -/- recipients of IL-10  -/- or WT cells at regular intervals 
via the tail vein. Blood cell concentrations were assessed using an 
automated counter (model 901;  Serono Diagnostics, Allentown, 
PA). Serum amyloid A  (SAA) levels were determined by ELISA 
using  a  kit  supplied by Biosource  (Camarillo,  CA)  as  per the 
manufacturer's direction. The statistical significance between ex- 
perimental groups was evaluated using a Student's unpaired t test. 
Histology and Immunohistochemistry.  A histological examination 
of the following tissues was performed: stomach, duodenum, il- 
eum, cecum, colon, rectum,  heart, liver, lung, spleen, and kid- 
ney. Tissues were isolated, trimmed of fat and connective tissue, 
either fixed in  10%  formaldehyde or immersed in  Tissue-Tek 
embedding compound  (Miles Scientific, Elkhart, IN),  and snap 
frozen  in  liquid  nitrogen.  Paraffin-embedded sections  (6  p~m) 
were stained with hematoxylin and eosin (H & E). Sections were 
graded  in  a  blinded  fashion  by  the  same  pathologist  (M.W. 
Leach).  Mouse  frozen colon sections  (4  p,m)  were  cut  using a 
Reichert-Jung  Frigocut  cryostat  (Cambridge  Instruments  Inc., 
Buffalo,  NY)  and  immediately air-dried onto  glass microscope 
slides. Monkey (M. nemestrina) tissue sections (MeDiCa, Carlsbad, 
CA),  including  colon,  kidney,  salivary gland,  and  esophagus, 
were used to ascertain the presence of tissue-reactive serum Ab. 
Mouse tissue sections were simultaneously stained with specific 
mAb  and  anticytokeratin using  a  two-step  protocol.  Sections 
were first rinsed in 1% (vol/vol) FCS in PBS and then incubated 
with 30 ~1 of primary mAb (as described above) and rabbit anti- 
cytokeratin in a humidified staining box for 20 rain at room tem- 
perature. Sections were washed three times for 5 min each by im- 
mersion in PBS.  Sections were then  incubated in a mixture of 
FITC-conjugated goat anti-rat IgG (~+L) and rhodamine-con- 
jugated goat anti-rabbit IgM and IgG (H+L) for a further 20 min 
and washed again as above. Monkey colon sections were stained, 
using the above protocol, with serum obtained from IL-10  -/- or 
WT mice which was diluted 1:10 and 1:100  in PBS.  Goat anti- 
mouse IgG-FITC was used to reveal mouse serum autoAbs. All 
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(Vector  Laboratories,  Burlingame,  CA)  under  glass coverslips. 
Sections  were  examined,  and photomicrographs taken,  using a 
Zeiss Axioskop fluorescence microscope (Carl Zeiss Inc., San Le- 
andro, CA) with 1600 ASA professional print film (Eastman Kodak, 
Rochester, NY). 
Lymphocyte Isolation and Flow Cytometry.  Gut lymphocytes  were 
isolated from WT and IL-10  -/- mice with rectal prolapses at 4-8 
mo of age according to a modified version of Lefran~ois (22). Ei- 
ther  the  entire  intestine  or the  large  [rowel  only was  isolated, 
trimmed of fat and connective tissue,  and lymphoid aggregates, 
including Peyer's patches,  were removed.  Intestinal  tissue,  after 
extensive  washing in PBS to remove fecal matter, was chopped 
and incubated in 2 mM EDTA in PBS for 30 rain at 37~  with 
stirring, to release intraepithelial  lymphocytes (IEL). The superna- 
tant,  containing IEL, was retained and tamiifia propria lympho- 
cytes (LPL) were subsequently  isolated from the remaining tissue 
fragments by incubation in 0.2 mg/ml collagenase/dispase  (Boeh- 
ringer Mannheim, Indianapolis,  IN) for 30 rain at 37~  with stir- 
ring.  The IEL and LPL preparations  were then washed  (5 min, 
350 g) and sieved  through nylon gauze (pore size, 100 ~m) fol- 
lowed by 70-~m  Falcon cell  filters  (Becton Dickinson  &  Co., 
Franklin  Lakes,  NJ)  to remove cell  clumps and larger epithelial 
cells. Lymphocytes were enriched by centrifugation within 40% 
(vol/vol) Percoll (Pharmacia  LKB,  Uppsala, Sweden)  overlaid on 
75% (vol/vol)  Percoll (20 rain,  750 g). Before cell sorting,  T  cells 
were enriched by depletion of B  cells, neutrophils,  and macro- 
phages.  Cell preparations  were incubated with B220,  8C5,  and 
Mac-1 culture supematants and Ab-stained cells were removed in 
a magnetic field using a combination of goat anti-rat IgG (Fc)- 
and goat anti-rat  IgG (H+L)-coated magnetic beads  (Advanced 
Magnetics,  Cambridge,  MA).  The remaining cells were stained 
with CD4-FITC and CD8o~-PE for 20 min on ice for subsequent 
cell sorting. 
For  flow  cytometry,  106  lymphocytes were  incubated  with 
mAb as described  above for 20 min on ice and washed in PBS/ 
FCS (5 min, 350 g). Cells were examined using a FACScan  |  flow 
cytometer equipped with CellQuest software  (Becton Dickinson 
& Co., San Jose, CA). Two-color cell sorting was performed using 
a FACStar Plus  |  (Becton Dickinson & Co.), sorted populations  be- 
ing >98% pure upon reanalysis. Unsorted LPL or IEL, or sorted 
LPL, were  injected  intravenously into  3-6-mo-old RAG-2  -/- 
mice in  100  I*1 PBS/FCS  containing 1,000  U  penicillin  and  1 
mg/ml streptomycin (Sigma Chemical Co., St. Louis, MO). 
Detection of Cytokine Expression by Flow Cytometry.  Cytokine 
production by lymphocytes isolated from the colon of RAG-2  -/- 
recipients  of either  IL-10  -/-  or WT LPL was  assessed after  in 
vitro stimulation with PMA and ionomycin according to Open- 
shaw et al. (23). Lymphocytes were isolated and surface molecule 
staining was performed as described  above. Intracellular  IL-4 was 
detected  in  fixed  and permeabilized  cells using  the  Ab  11Bll 
conjugated to PE, whereas FITC-conjugated AN18 revealed the 
presence of IFN-y. A TH1  cell line,  CDC25, producing IFN-~/ 
but not IL-4, and a TH2 clone, DC.11.10, producing IL-4 but 
not IFN-',/, were used as positive  controls after in vitro stimula- 
tion (provided by Dr. A. O'Garra). 
Results 
The Frequency  of Colonic  Ig  +  Cells Is Enhanced  and Serum 
Colon-reactive Abs Can Be Detected in IL-10 -/- Mice.  A  pos- 
sible role for B  cells as a mediator oflBD in IL-10  -/- mice 
was evaluated.  An increased frequency of Ig  + cells was de- 
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tected by immunofluorescent staining of frozen colon sec- 
tions in the lamina propria oflL-10 -/- mice compared with 
WT mice (Fig.  1, A  and B). The degree of diffuse staining, 
indicative  of secreted  Ig,  was  also  enhanced  in  IL-10  -/- 
mice. As IgG1 autoAbs have been implicated in the patho- 
genesis  of ulcerative  colitis  in  humans  (8,  9),  sera  from 
IL-10  -/-  and WT  mice were tested on frozen sections  of 
monkey  colon  for  colon-reactive  IgG  using  a  ~/-specific 
secondary  Ab.  Table  1  indicates  that  IgG  reactive  with 
monkey  colon  were  present  in  the  sera  of ~60%  of 
IL-10  -/-  mice  <6  mo of age.  In contrast, such Ab were 
absent in the sera of WT mice in this age range  (Table  1). 
The staining pattern of the sera Ab from IL-10  -/- but not 
WT  mice included both crypt and surface epithelium  and 
lamina  propria  cells  (Fig.  1,  C  and  D).  Reactivity  with 
other monkey tisstles,  including kidney, salixiary gland  and 
esophagus,  was not detected with either IL-10  -/-  or WT 
sera. In mice >6 mo of age, 75% oflL-10 -/- mice had co- 
lon-reactive  serum  IgG,  this  frequency  reflecting  the  in- 
creased severity of their disease with age (Table 2; data for 
B +/+ IL-10  -/-  mice).  Interestingly,  37% of WT  mice >6 
mo  of age  also  developed  colon-reactive  IgG.  Therefore, 
the functional significance of colon-reactive Abs in IL-10  -/- 
mice required further clarification. 
B  Cell-deficient IL-10-/-  Mice Develop IBD.  To  ascer- 
tain the functional significance of abnormal B cell responses 
in  IBD,  IL-10  -/-  mice  were  crossed  with  mice  lacking 
mature B  cells due to a deletion of the membrane exon of 
the Ig ~  chain gene (21).  The gastrointestinal tract and other 
major organs of  B-/-IL-10  -/- and B+/+IL-10-/- mice were 
assessed  for pathological  alterations  (Table  2).  Pathologic 
changes detected in the colon of B-/-IL-10  -/- mice at 3-6 
mo of age were mild, similar to those of B+/+IL-10  -/- mice 
in this age range. These changes consisted of colitis charac- 
terized  by multifocal  epithelial  hyperplasia  and  leukocyte 
infiltration  into  the  lamina propria  of the  cecum and  de- 
scending colon. At 6 mo of age, severe colitis was seen in 
the  majority  of B-/-IL-10  -/-  mice  examined,  character- 
ized by extensive leukocyte infiltration  of the lamina pro- 
pria  and  marked  epithelial  hyperplasia.  Rectal  prolapses 
were  also  observed  and  high  peripheral  blood  leukocyte 
and platelet counts were detected  (data not shown).  These 
pathologic and clinicopathologic findings were comparable 
with  those  seen  in  age-matched B+/+IL-10  -/-  mice  (18; 
Table  2).  Control B-/-IL-10  +/+  and B+/+IL-10  +/+  mice 
showed no clinical or microscopic indication of colitis at any 
time points tested. These data indicate that neither B cells nor 
Abs were necessary for the initiation and maintenance oflBD. 
Adoptive  Transfer  of LPL or IEL from  IL-IO -/-  Mice into 
RAG-2 -/-  Mice Results in IBD.  A  role for T  cell media- 
tion oflBD in IL-10  -/- mice was then assessed  using a cell 
transfer model in which LPL or IEL prepared from the en- 
tire  gut  of IL-10  -/-  or WT  mice were  adoptively trans- 
ferred  into  RAG-2 -/-  immunodeficient  hosts.  Both  the 
LPL and IEL preparations  from IL-10  -/-  mice were com- 
prised primarily of al3TCR + T  cells,  many of which were 
CD4+CD8a -  or CD4+CD8oL  +, as previously documented 
(18).  In contrast,  the WT  LPL and IEL preparations  were Figure  1.  Distribution  of Ig  + 
cells and  reactivity  of serum  Ab 
in  the  colon  of lL-10  -/-  and 
WT  mice.  In  all  photomicro- 
graphs,  rhodamine  staining (red) 
of  cytokeratin  defines epithelial 
cells. (A and B) Frozen tissue sec- 
tiom of  mid-colon 8om 8-mo-old 
animals were stained with an anti- 
mouse  Ig-AMCA Ab.  (A)  lg  + 
cells were  scattered  throughout 
the lamina propria of  the IL-10  -/ 
colon, and diffuse staining, indic- 
ative  of secreted  Ig,  was  clearly 
evident.  (B) Few Ig  + cells (arrow) 
and  relatively litde  diffuse stain- 
ing was detected in the WT colon. 
(C)  The  serum  from  IL-10 -/- 
mice stained (FITC3 luminal sur- 
face and crypt epithelial cells (yel- 
low labeling indicates coincident 
staining ofsemm Ab and anticy- 
tokeratin)  and nonepithelial  cells 
of the lamina propria in monkey 
colon tissue sections.  (D)  Serum 
from WT animals  showed only 
a  background  reactivity  (FITC) 
with monkey colon.  ￿  110. 
almost  devoid of CD4+CD8ot +  cells,  and  the  IEL fraction 
contained  a  high  frequency  of ySTCR. +  and  CD8ct +  T 
cells,  in  accordance  with previous  studies  (24).  The  com- 
position  of the transferred  populations  and  the outcome of 
the cell transfers are summarized in Table 3. 
RAG-2 -/-  recipients  of the  above  cell  fractions  were 
monitored for 10 wk and then assessed for IBD. All recipi- 
ents  of IL-10 -/-  and  WT  LPL  showed  lymphoid  recon- 
stitution  of the  gut  (Fig.  2).  However,  only  recipients  of 
IL-10 -/-  LPL developed severe inflammation of the colon 
(Table  3).  Recipients  of the  highest  number  of IL-10  -/- 
LPL  (2  ￿  10  6)  were  severely  affected  by  2  wk  post-cell 
transfer,  one  individual  suffering  from  necrotizing  cohtis. 
Other  organs  and  tissues  were  examined,  including  the 
stomach,  small  intestine,  heart,  liver,  lung,  and  kidney, 
Table 1.  Incidence  ofColon-mactiveAbinlL-lO -/- 
and WTMice 
Mouse strain  Age  Anticolon Abs 
mo 
IL-10 -/-*  3-6  7/11* 
>6  3/4 
IL-10 +/+  3-6  0/6 
>6  3/8~ 
"12/15 IL-10  -/- mice showed rectal prolapse. 
*Serum positive at both 1:10 and  1:100 dilutions. 
~WT mice aged 7, 8, and 12 too, all appeared  healthy. 
none of which was significantly affected. The inflammatory 
lesions  induced  in  the  colon  of RAG-2 -/-  recipients  of 
IL-10 -/-  LPL were multifocal,  consisting ofa mucosal and 
often  submucosal  infiltration  of lymphocytes,  plasma  cells, 
and  neutrophils.  Epithelial  hyperplasia  was  observed,  giant 
cells  were  scattered  throughout  the  lamina  propria,  and 
Table 2.  Incidence and Severity of lBD  in B  Cell-deficient 
IL- 10-/-  Mice 
Colitis* 
Mouse strain  Age  Normal  Mild  Severe 
mo 
B -/- IL-10 -/-  3-6  0/20  20/20  0/20 
>6  0/8  1/8  7/8 
B +/+ IL-10 -/-  3-6  2/20  14/20  4/20 
>6  0/15  6/15  9/15 
B -/- IL-10 +/+  3-6  8/8  0/8  0/8 
>6  N/A*  N/A  N/A 
B §  IL-10 +/+  3-6  10/10  0/10  0/10 
>6  8/8  0/8  0/8 
*  Colon/caecum pathology graded as follows: normal:  indistinguishable 
from normal or unmanipulated control mice; mild: low degree of leu- 
kocyte  infiltration  and  slight  epithelial  hyperplasia;  severe:  extensive 
leukocyte infiltration,  often transmural,  marked epithehal  hyperplasia, 
loss of goblet cells, crypt abcesses and ulceration. 
*Mice not available. 
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LPL or IEL  IL-10  +/+ LPL  IL-10-/" LPL 
Colitis* 
P,  econstitution  Normal  Mild  Severe 
LPL*  1 X  10  5  IL-10  -/-  0/4  0/4  4/4 
IL-10 +/+  3/4  1/4  0/4 
5 ￿  10  s  IL-10  -/-  0/4  1/4  3/4 
IL-10  +/+  4/4  0/4  0/4 
2  X  10  6  IL-10  -/-  0/6  2/6  4/6 
IL-10 +/+  4/4  0/4  0/4 
IEL~  1 ￿  10  5  IL-10 -/-  2/4  1/4  1/4 
IL-10  +/+  4/4  0/4  0/4 
5 ￿  10  s  IL-10  -/-  1/4  2/4  1/4 
IL-10 +/+  4/4  0/4  0/4 
* Colon pathology assessed 10 wk post-cell transfer except for recipients 
of 2 ￿  106 LPL which were assessed at 2 wk after transfer due to the se- 
verity of colon inflammation. Degree  of colon pathology  defined in 
legend to Table 2. 
*Phenotype:  IL-10-/-:  55%  otJ3TCR.  +,  7%  "/~TCR  +,  23%  CD4 + 
CD8ot-, 20% CD4+CD8ci +, 13% CD4-CD8ot+; WT:40% otJ~TCR.  +, 
7% "/BTCR  +,  25%  CD4+CD8ot -,  <1%  CD4+CD8ot +,  13% CD4- 
CD8ot +. 
~Phenotype:  IL-10-/-: 75%  ~xl~TC!a.  +,  17%  ~/BTCR.  +,  11%  CD4 + 
CD8~x-, 33% CD4+CD8o<  +, 35% CD4-CD8cx+; WT: 52% eq~TCP, +, 
27%  "~STCR +,  <1%  CD4+CD8oe -,  <1%  CD4+CD8~x +,  55% 
CD4-CD8o~  + (phenotypic data indicate lymphoid composition and are 
representative of three independent experiments). 
crypt abscesses were  common. These pathological changes 
were  similar to  those  documented for  IL-10 -/-  mice  (16, 
17,  18),  however,  the lesions in IL-10 -/-  mice were more 
localized to  discrete areas of the organ, and giant cells and 
crypt abscesses,  although present, were  less common. R.e- 
cipients of WT  LPL showed no evidence of colitis but for 
one  mouse  with  minimal disease.  IL-10 -/-  IEL,  but not 
WT  IEL, also induced colitis in recipient mice, although it 
was  not  as  severe  as  that  induced  by  IL-10  -/-  LPL.  All 
other organs examined were unaffected. 
Phenotypic Characteristics of Inflammatory Lymphocytes.  The 
phenotype of the IL-10 -/-  or WT  cells infiltrating the co- 
lons  of RAG-2 -/-  mice  10  wk post-cell  transfer  of LPL 
were  analyzed.  In  all  recipients,  T  cells  expressing  the 
cx[~TCP,, were recovered from both the epithelium and the 
lamina propria of RAG-2 -/-  recipients, whereas very few 
~/8TCP,  +  cells were  detected  (Fig.  2).  Although all CD4/ 
CD8o~-defined T  cell populations could be detected in re- 
cipients of either IL-10 -/-  or WT  LPL, a striking increase 
in the  frequency of CD4+CD8ot +  T  cells in recipients of 
IL-10 -/-  LPL was  evident.  Considering that cell recovery 
in recipients of IL-10 -/-  LPL was threefold greater than in 
recipients  of  WT  cells,  a  12-fold  absolute  increase  in 
CD4+CD8oL +  had  occurred  in  the  former,  indicating  a 
preferential  expansion  of these  ceils.  Another  difference 
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Figure 2.  FACS  |  analysis  of gut lymphocytes isolated from the epithe- 
hal and lamina propria  compartments  of RAG-2  -/- mice  transplanted 
with WT or IL-10 -/- LPL. RAG-2  -/- mice were injected with 5 X 105 
WT or IL-10 -/- LPL, the lymphoid populations were recovered and an- 
alyzed  10  wk  after  transfer. (A)  The  expression  of cq~TCR  versus 
"/BTCP, on lymphoid-gated  cells isolated from the host RAG-2  -/- epi- 
thelial and lamina propria  compartments.  (B) The distribution  of CD4 
versus CD8 on gated CD3 + T cells. Expression of(C) CD45RB and (D) 
CD44 on gated CD4  + lymphocytes. 
noted  was  the  high  frequency  of CD4-CD8ci +  T  cells 
found in the gut ofWT  LPL recipients (Fig. 2). However, 
calculations revealed that the absolute number of these cells 
was not greatly different from recipients of IL-10 -/-  LPL. 
The CD4 + cells that homed to the host gut, regardless of 
their  source,  expressed  an  activated/memory  phenotype, 
being predominantly CD45RB -/l~  and  CD44 +  (Fig.  2). 
This finding was not surprising considering that activated/ 
memory cells traffic more efficiently from the blood to pe- 
ripheral  tissues  than  do  naive cells  (25).  Interestingly, re- 
gardless of whether  LPL  (Fig.  2)  or IEL  (data not shown) 
were transferred from WT  or IL-10 -/-  mice, lymphocytes 
could  be  recovered  from  both  the  epithelial  and  lamina 
propria  compartments  of recipient mice.  This distribution 
of cells  was  also  clearly  observed  by  immunofluorescent 
staining of tissue sections (data not shown). This is likely to 
result from significant cell traffic  occurring back and forth 
between the epithelial and lamina propria compartments (24). 
When IEL were transferred, similar results were obtained 
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Figure 3.  Development oflBD 
in RAG-2  -/- recipients of sorted 
IL-10  -/-  LPL. RAG-2  -/-  mice 
were  injected  with  sorted  LPL 
isolated  from  IL-10 -/-  colon: 
(square)  5  ￿  10  s CD4+CD8o~-; 
(diamond) 5 ￿  104 CD4+CD8oL-; 
(open circle) 10  s CD4+CD8~x+; and 
(triangle) 3  ￿  105 CD4-CD8ot  +. 
(A)  SAA,  (/3) peripheral  leuko- 
cyte, and (C) platelet counts were 
measured every 2 wk for 10 wk. 
The statistical significance  between 
values for each group was assessed 
using an unpaired Student's t test. 
From 4-6 wk post-cell  transfer, 
the  values  for recipients  of any 
CD4-expressing  population  did 
not differ statistically  from one an- 
other but were significantly  greater 
than those of CD4-CD8~x + LPL 
recipients.  Data  represent  the 
mean of two independent exper- 
iments  involving multiple  mice 
per group. 
(data not shown).  The phenotype oflymphocytes recovered 
from the colon epithelial and lamina propria compartments 
of R.AG-2 -/-  recipients  of either  WT  or  IL-10  -/-  IEL 
was  comparable  with  that  after  transfer  of LPL.  Further- 
more,  IEL  could  also  reconstitute  both  the  epithelial  and 
lamina propria compartments of the RAG-2 -/-  mouse colon. 
RAG-2  -/-  Recipients  of CD4+ CDSa -  or  CD4+ CDSa  + 
IL-I0 -/-  LPL  Develop  IBD.  To  determine  which  T  cell 
subsets  could mediate colitis, CD4+CD8ot -, CD4+CD8cx +, 
and  CD4-CD8er +  T  cells  were  sorted  from  the  lamina 
propria  of colitis-affected  IL-10 -/-  mice  and  transferred 
into  RAG-2 -/-  hosts.  Characteristics  indicative  of an  in- 
flammatory  response,  such  as  SAA  levels  and  peripheral 
blood leukocyte and ptatelet  counts,  were monitored peri- 
odically in recipient mice for 10 wk to assess  the kinetics of 
IBD  development  (Fig.  3).  Recipients  of  either  CD4 +- 
CD8cx-  or  CD4+CD8ot +  IL-10 -/-  LPL  showed  steadily 
increasing SAA levels, leukocyte and platelet numbers  over 
the  10-wk period.  These values were statistically compara- 
ble, suggesting that both of these subsets could induce signs 
of inflammation at an equivalent rate.  The SAA, leukocyte, 
and platelet values of recipients of IL-10 -/-  CD4-CD8o~ + 
LPL  were  not  different  from  values  for  unmanipulated 
RAG-2 -/-  mice (data not shown). 
A  histological assessment  of transplanted  RAG-2 -/-  re- 
cipients  confirmed  that  both  CD4+CD8e~ -  and  CD4 § 
CD8oL  + LPL from IL-10 -/-  mice could induce IBD (Table 4, 
Fig.  4).  Recipients  of CD4+CD8ot -  LPL,  irrespective  of 
the  cell  number  administered  (10-fold  range),  developed 
severe  colitis  that  was  comparable  with  that  in  donor 
IL-10 -/-  mice (Fig. 4, A  and B). The colitis featured diffuse 
inflammation with a mucosal and submucosal infiltration of 
lymphocytes and neutrophils,  numerous  multinucleated gi- 
ant  cells,  crypt  abscesses,  and  epithelial  hyperplasia.  This 
inflammation  was  similar  to  that  induced  by  unseparated 
IL-10 -/-  LPL.  In contrast,  recipients ofWT  CD4+CD8o~ - 
LPL showed only a limited leukocyte reconstitution  in the 
Figure 4.  IBD can be induced 
in  RAG-2  -/-  recipients  of 
CD4+CD8~x  -  or  CD4+CD8o~  + 
IL-10 -/-  LPL.  (A-D)  Colon 
sections  stained  with  H  &  E. 
Colon inflammation is character- 
ized  by extensive  mucosal  (short 
arrow)  and  suhmucosal  (long ar- 
row) mononuclear cell infiltration 
and  epithelial  cell  hyperplasia. 
(A) Donor IL-10 -/- mouse;  (/3) 
RAG-2  -/- recipient of IL-10 -/- 
CD4+CD8~x  -  LPL; (C)  KAG- 
2 -/-  recipient  of  IL-10 -/ 
CD4+CD8cr +  LPL; (D)  RAG- 
2 -/-  recipient  of CD4-CD8c~  + 
LPL;  and  (E)  unmanipulated 
RAG-2  -/- colon.  ￿ 
246  Colitis in IL-10  -/- Mice Is Mediated by CD4  + T  Cells Table 4.  Colitis  in RAG-2 -/- Mice after Reconstituiton with 
CD4 / CD8-defined  LPL 
Colitis* 
Phenotype of LPL 
inoculum  Normal  Mild  Severe 
CD4+CD8ce -  IL-10  -/-  5 ￿  10  s  0/5  1/5  4/5 
5  ￿  104  0/9  3/9  6/9 
IL-10  +/+  1 X  10  s  2/3  1/3  0/3 
CD4+CD8e~ +  IL-10  -/-  1 X  105  0/5  5/5  0/5 
5  X  104  0/8  8/8  0/8 
IL-10  +/+  ND~: 
CD4-CD8ot +  IL-10  -/-  3  X  105  4/4  0/4  0/4 
1  ￿  10  s  3/3  0/3  0/3 
IL-10  +/+  1 X  105  4/4  0/4  0/4 
*Colon  pathology  (defined  in  legend to  Table  2)  assessed 10-12  wk 
post-cell transfer. 
*Not done as extremely low number of CD4+CD8~x  +  T  cells present 
in IL-10 +/+ lamina propria. 
colon. One WT  animal showed a multifocal inflammation 
that was less severe than recipients of IL-10 -/-  cells. None 
of the recipients showed significant pathology in any other 
organs examined. RAG-2 -/-  recipients oflL-10  -/- CD4 +- 
CD8ot + LPL also suffered from colitis (Fig. 4  C), although 
it was not as severe as that induced by an equivalent num- 
ber ofCD4+CD8ot -  LPL (5  ￿  104 cells, Table 4).  In con- 
trast, colitis did not develop in recipients of either IL-10 -/- 
or WT  CD4-CD8ot §  LPL. The colons of these mace were 
microscopically  identical  to  unmanipulated  RAG-2 -/- 
mice (Fig. 4, D  and E), and flow cytometry revealed a lack 
of lymphoid reconstitution (data not shown). 
Immunohistological  studies  demonstrated  the  distribu- 
tion of CD4 + and CD8o~ + T  cells in the colon of diseased 
RAG-2 -/-  recipients of IL-10  -/-  T  cells. When  CD4 +- 
CD8ot- LPL were transferred into RAG-2 -/-  mice, CD4 + 
(Fig. 5 A) and CD8ot +  (Fig. 5  B)  cells were clearly evident 
in both the epithelial and lamina propria compartments of 
the  host  colon.  Neither  CD4 +  nor  CD8 +  lymphocytes 
were  detected in  the  colon  of unmanipulated  RAG-2 -/- 
mice  (data not  shown).  Flow cytometric  analysis of lym- 
phocytes  recovered from  the  colon  of RAG-2 -/-  recipi- 
ents of IL-t0  -/- CD4+CD8c~ -  LPL revealed that all lympho- 
cytes  expressing  CD80l  coexpressed  CD4.  Although  the 
proportion of transplanted CD4+CD8ot -  LPL that acquired 
CD8ot  expression in the RAG-2 -/-  host was variable be- 
tween  experiments  (20--80%),  the  majority of cells  consis- 
tently remained CD45RB -/l~  and CD44 + (data not shown). 
Cytokine  Production  by  IL-IO  -/-  LPL  Subsets  Recovered 
from RAG-2 -/-  Recipients.  Lymphocytes  were  isolated 
from  the  colon  of RAG-2 -/-  recipients of either WT  or 
IL-10  -/-  LPL. The ability of these cells to produce IFN-~/ 
and  IL-4  was  assessed by flow  cytometry after  a  brief in 
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Figure  5.  (A  and  B)  Colon  of  RAG-2  -/-  recipient  of  IL-10  -/- 
CD4+CD8ct -  LPL. Frozen tissue sections stained with rhodamine-conju- 
gated anticytokeratin to reveal epithelial cells (red)  and either FITC-con- 
jugated anti-CD4 (A) or anti-CD8ot (B). (Arrows) IEL.  ￿  110. 
vitro  stimulation.  The  results  clearly show  that  IL-10  -/- 
otJ3TCR. +  T  cells  recovered  from  RAG-2 -/-  mice  with 
colitis produced IFN-y, but very little IL-4 (Fig. 6).  Inter- 
estingly, WT otJ3TCP.. + T  cells isolated from recipients that 
did not have colitis also produced IFN-~/but not IL-4. As 
three- to fourfold more lymphocytes were recovered from 
recipients of IL-10  -/-  LPL as compared with WT  LPL, we 
presumed  that  the  former  possessed  significantly more  T 
cells capable of producing IFN-% 
This  hypothesis was  confirmed by further  analysis of T 
cell subsets isolated from the lamina propria of RAG-2 -/- 
mice  reconstituted with  WT  or  IL-10  -/-  LPL.  A  larger 
number  of CD4+CD80t -  and  CD4+CD8ot +  lymphocytes 
were present in recipients oflL-10 -/-  LPL that were capa- 
ble of  producing IFN-~/(Table 5). This represented a 7- and 
22-fold  increase,  respectively,  in  the  number  of IFN-~/- 
producing cells present among the CD4+CD8ot -  and CD4 +- 
CD8ot + IL-10 -/-  LPL compared to that of WT  cells. 
Perhaps the most striking finding was that we could de- 
tect ~120 pg/ml of IFN-~/in the sera of RAG-2 -/-  recip- 
ients oflL-10 -/- LPL, whereas this cytokine was undetect- 
able in the sera of recipients without colitis. TH1 & TH2 CELLS 
F 
Control  anti-IFN-y 
o 
RAG-2  4- recipient of 
IL-10  +1+ LPL  IL-10-/- LPL 
12  <1  75  <1 
~.  ~  Figure  6.  Cytokine  produc- 
￿9  <1  ~ ~':~  <1  don by LPL recovered from the 
colon of transplanted RAG-2  -/- 
Control Ig  I=  mice.  A  TH1  cell  line  and  a 
44  3  76  a  TH2  clone  were  mixed  after 
stimulation and included as posi- 
~,;'..  ~  ["~  tive  controls for  cytokine  stain- 
I~ ~'~'-'"  "-~"'%...  1  ing  (top).  Lymphocytes  were 
isolated  from  the  colons  of 
tl  anti-lL-4  ~  RAG-2  -/- mice 8 wk post-cell 
lc  54  20  transfer  of  either  106  WT  or 
IL-10 -/-  LPL  and  stained  for 
:'  ~,~'.['  ~i!"  ....  IFN-'~ and IL-4 production after 
r  ~;/~; ~.!%....  <~,/.:.  4 h  of in vitro stimulation  (bot- 
.  .  ~  "  a  tom).  The results are representa- 
,t  anti-IFN~  ~  rive of two experiments. 
Discussion 
IL-10 -/-  mice develop chronic enterocolitis that is char- 
acterized by extensive epithelial hyperplasia, intense mono- 
nuclear infiltration of the mucosa, and a high incidence of 
colorectal carcinoma (16,  17,  18). Our aim was to ascertain 
which  cell types are  primarily involved in mediating IBD 
in the IL-10 -/-  mouse model. 
A  pathogenic role for intestinal B  cells and Abs has been 
implicated by a number of recent findings. Serum IgA and 
IgG1 levels are elevated in IL-10  -/-  mice  (16),  and serum 
IgG from IL-10 -/-  mice has been shown to react with en- 
teric bacterial antigens by Western blotting (Elson, C.,  and 
S. Brandwein, University of Alabama, Binmngham, AL, per- 
sonal communication). These findings are consistent with our 
demonstration herein that the frequency of Ig  + cells in the 
colon lamina propria was increased in IL-10 -/-  mice. Given 
that  human  IBD  patients  may  possess  potentially  patho- 
genic autoAbs that cross-react with enteric flora (1-3, 6, 7), 
we examined the cross-reactivity of IL-10  -/-  serum Ig with 
various monkey tissues. IgG reacting specifically with colon 
epithelial and nonepithelial cells was present in the majority 
of IL-10 -/-  sera tested.  To ascertain the role of these Abs, 
we  generated  a  B  cell-deficient strain  of IL-10  /-  mice. 
The finding that IBD develops in B-/-IL-10 -/- mice indi- 
cated that neither B  cells nor their Ab products were nec- 
essary  for  the  initiation  or  perpetuation  of  IBD  in  the 
IL-10 -/-  mouse model. Therefore,  our data would suggest 
that  colon-reactive  Abs  in  IL-10 -/-  mice  are  simply  an 
epiphenomenon related to inflammation of the colon. 
The  inflammatory  infiltrate  in  the  colon  of  colitis- 
affected IL-10  -/-  mice also included abnormally high num- 
bers of activated/memory (xl3TCR. +  T  cells expressing ei- 
ther  CD4  alone  or in combination with  CD8&  (17,  18). 
These  cells  were  capable  of producing  large  amounts  of 
IFN-'y but tittle'or no IL-4 after in vitro stimulation, suggest- 
ing a pathogenic role for THl-like  T  cells in the IL-10 -/- 
mouse model of IBD. The present study has clearly demon- 
strated that  IL-10 -/-  LPL can induce colitis upon transfer 
to immunodeficient RAG-2 -/-  recipients whereas WT  cells 
had no such effect. The inflammation induced in RAG-2 -/- 
mice by IL-10  -/-  LPL was characterized by extensive mono- 
nuclear  infiltration of the  colonic  and  cecal  mucosa  and 
submucosa,  epithelial cell hyperplasia,  and  crypt abscesses. 
This profile was  similar to  the  major features  of IBD  ob- 
served in donor IL-10 -/-  mice (16-18).  IEL isolated from 
IL-10 -/- mice also appeared to have the capacity to induce 
colitis  in RAG-2 -/-  recipients,  albeit less  efficiently than 
Table  5.  Cytokine Production  by T  Cell Subsets Recovered fiom the Lamina Propria of RA G-2-/-  Mice Transplanted with IL-t 0 +  / + 
or lL- l O  -/-  LPL 
Source of donor lymphocytes: 
IL-10  +/+ LPL  IL-10  -/- LPL 
No. of cells 
T  cell subset recovered  (￿  10 -4) producing: 
from host RAG-2  -/  Total no. cells  Total no. cells 
lamina propria  (￿  10 -4)  tL-4  IFN-~/  (X 10 -4) 
No. of cells 
(5( 10 -4) producing: 
IL-4  IFN-y 
CD4+CD8c~ -  20.4*  1.4'  3.6  93.9*  1.5*  24.9 
CD4+CD8ot +  1.4  0.2  0.2  t5.1  0.3  4.5 
*Average number of CD4/CD8-defined lymphocytes recovered per colon from a pool of four mice. 
SData indicate total number ofT cells in each defined subset producing IL-4 or IFN-% LPL were recovered  from the colons of RAG-2  -/- nfice 8 
wk after transfer of either 10  6 IL-10  +/+ WT or IL-10  -/- LPL and stained for IFN-'y and IL-4 production after 4 h of in vitro stimulation. Total co- 
lon lymphocyte recovery from individual RAG-2 -/- recipients oflL-10  +/+ LPL was (6.0 +- 6.9) ￿  10  5 and recovery from RAG-2 -/- recipients of 
IL-10  -/- LPL was (I6.8 +- 7.2) X 10  s. The results are representative of two to four experiments. 
248  Colitis in IL-10 -/  Mice Is Mediated by CD4 + T Cells IL-10  -/-  LPL.  However,  given  that  LPL  can  traffic  be- 
tween the epithelial and lamina propria compartments  (24, 
and Figs.  2  and 5),  we suspect that colitis-causing effector 
cells present within the IL-10  -/-  IEL may have originated 
from the lamina propria. 
Analysis of  the infiltrating lymphocytes after transfer of LPL 
revealed that the expansion of IL-10  -/- cells in RAG-2  -/- 
recipients  was  three-  to fourfold greater than  that  of WT 
cells.  The phenotypic profile of donor lymphocytes recov- 
ered from the epithelial or lamina propria compartments of 
either  groups  of recipients  was  similar.  The  majority  of 
lymphocytes  were  0t[3TCR +  and  those  expressing  CD4 
were mainly activated/memory cells,  being CD45RB -/l~ 
and CD44 +. The most striking difference between the ex- 
perimental groups was a large increase in the absolute num- 
ber of CD4+CDScx + lymphocytes found in both the lamina 
propria and the epithelial  compartments  of R.AG-2  -/-  re- 
cipients  of IL-10  -/-  cells.  This  very  high  incidence  of 
CD4+CD8r  + lymphocytes implicated a role for this T  cell 
subset in the disease process. 
To  determine  which  populations  of IL-10  -/-  T  cells 
could  mediate  IBD,  we  adoptively  transferred  purified 
CD4+CD8ot -,  CD4+CD8ot +,  or CD4-CD8ot +  LPL into 
R.AG-2  -/-  recipients.  The  ability  of CD4+CD8a -  and 
CD4+CD8ot +  T  cell  subsets  to  induce  colitis  was  con- 
firmed by histological analysis of colon tissues.  The kinetics 
of disease  development,  as  measured  by  SAA, peripheral 
leukocyte,  and  platelet  values were  statistically  comparable, 
indicating that these two populations of T  cells had similar 
functional  abilities  with  respect  to .IBD induction.  Colitis 
was not induced by IL-10 -/-  CD4-CD8a + LPL as  these 
cells failed to reconstitute the gut. Other reports have doc- 
umented the inability to establish a population of CD8 + T 
cells  in  the  gut  and  other  organs  of scid  mice  (26,  27). 
CD4-CD80~ +  T  cells  could  be  detected  in  the  gut  of 
RAG-2  -/- mice after reconstitution with unseparated LPL 
or IEL, suggesting that CD8 + T  cells do not home well to 
gut tissues and/or do not proliferate upon arrival in the ab- 
sence of help  from other T  cell subsets.  Hence,  a role for 
CD8 + T  cells in the pathogenesis of IBD in IL-10  -/- mice 
cannot be  excluded,  although they were  not required  for 
transfer of the disease to immunodeficient hosts (this study; 
13, 14, 28, 29). 
We have demonstrated herein that CD4+CD8r  + T  cells 
isolated  from the  lamina  propria  of IL-10  -/-  colon were 
capable  of inducing  IBD in  RAG-2  -/-  mice.  This  result 
was  surprising  given  that  CD4+CD8ot +  T  cells  are  nor- 
mally present in the epithelial compartment of the small in- 
testine  and  are  nonpathogenic  (24).  Recent  studies  have 
demonstrated  that  they derive  from CD4+CD8o~ -  T  cells 
(30, 31).  CD4+CDSo~ + T  cells are conspicuously absent in 
the small intestine  of germ-free rodents  (32,  33), implying 
that the acquisition of CD8~x by CD4 + T  cells is driven by 
a response  to enteric flora.  In support  of this premise,  hu- 
man CD4 + T  cells  will synthesize and express CD8ot after 
mitogen-induced activation (34, 35).  Compared with con- 
ventional  CD4+CD8ot -  lymphocytes,  CD4+CD8ot +  IEL 
exhibit poor proliferative  responses  to in vitro stimulation 
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with  nominal  antigen,  superantigens,  or anti-TCR  mAbs 
(25,  36).  This low proliferative  potential  may explain  the 
failure of CD4+CD8et + T  cells purified from normal mice 
to reconstitute  the tissues of scid mice (30).  Other in vitro 
studies have shown that CD4+CD8et + IEL can become cy- 
totoxic upon TCR  triggering (36) and can produce various 
cytokines including IFN-'y (37). Presently, the in vivo role 
ofCD4+CD8cx + T  cells in mucosal immunity is not known. 
Herein,  we have  demonstrated  that  CD4+CD8ot + T  cells 
derive  from  CD4+CD8o~ -  LPL  during  a  pathogenic  re- 
sponse and they can mediate  IBD in immunodeficient re- 
cipients  in the  absence  of" other T  cell subsets.  However, 
their pathogenic potential was not as great as CD4+CD8a - 
LPL in this  transfer model.  Given that  CD4+CD8a +  cells 
may have a low proliferative potential  (25, 26), the expan- 
sion of effector cells upon transfer to R.AG-2  -/-  mice may 
be less  efficient  than  that  of CD4+CD8ot -  LPL.  Alterna- 
tively, CD4+CD8ot + LPL may not home to the gut as well 
as  CD4+CD8ot -  LPL.  Regardless,  CD4+CD8ot +  T  cells 
are clearly an effector of IBD in IL-10  -/- mice and, there- 
fore, have a pathogenic potential that has not been hereto- 
fore identified for this T  cell subset. 
To assess the pathogenic function of transplanted IL-10  -/- 
cells,  T  cells  recovered  from  RAG-2  -/-  recipients  of 
IL-10  -/-  or WT LPL were analyzed for cytokine produc- 
tion. No differences between IL-10  -/- and WT LPL were 
observed  as  both populations  included  cells  that  could be 
induced to produce IFN-~/in vitro, whereas few cells from 
either subset produced IL-4. This implied that IL-10  -/-  T 
cells reconstituting  RAG-2 -/-  recipients  were not abnor- 
mally skewed towards a TH1 phenotype, although in terms 
of absolute  numbers,  THl-like  cells  were more abundant 
in the diseased recipients. A  more relevant finding was that 
IFN-~/could be detected in the sera of RAG-2  -/-  recipi- 
ents with colitis. Apparently, a TH1  response in the colon 
becomes pathogenic  when  it  results  in  the  excessive pro- 
duction of cytokines such as [FN-~/. 
It is clear that IL-10 plays a fundamental role in the con- 
trolled  development  of TH1  mucosal  responses  in  vivo. 
Exaggerated IFN-y production was readily detected in the 
original  donor  IL-t0  -/-  mice  (18),  but  interestingly, 
IL-10  -/-  T  cells  continued  to  produce  large  amounts  of 
IFN-~/  after  reconstituting  RAG-2  -/-  tissues  that  con- 
tained  macrophages and epithelial  cells capable of produc- 
ing IL-10 (19, 20). This observation suggests that the most 
critical source of IL-10 is the T  cells  themselves.  Recently, 
a murine model oflBD has been described where C.B-17 
scid mice develop severe colitis after reconstitution with the 
CD45R.B  hi  fraction  of CD4 +  spleen  cells  from  normal 
BALB/c mice (13,  14, 28).  The CD45RJ31~  + splenic 
T  cells  had no such effect and,  when  coinjected with  the 
CD45RB  hi fraction,  were  able  to prevent  colitis  develop- 
ment. It was found that colitis induction by CD45RBr'CD4+ 
T  cells was due to their elevated IFN-y and TNF produc- 
tion (13, 28).  It has been proposed that CD45RBl~  + 
T  cells contain a regulatory subset that inhibits the in vivo 
TH1  responses  of CD45P,.BhiCD4 +  cells.  This  regulation 
may involve IL-10 as systemic treatment  of scid recipients of CD45RBhiCD4+  T  cells with IL-10 prevented the de- 
velopment of colitis (28). 
As IL-10  -/-  mice and CD45RBhiCD4 + T  cell-reconsti- 
tuted scid mice are models of IBD involving a pathogenic 
CD4 +  TH1  response,  a  comparison  of these  systems  is 
highly informative.  The  induction  of colitis by  IL-10  -/- 
CD4 +  LPL  did  not  depend  upon  their  separation  into 
CD45RB hi  and  CD45RB l~  fractions.  Furthermore,  the 
majority of IL-10 -/-  CD4 + LPL used in these reconstitu- 
tion  studies  were  CD45RB l~  possessing the  phenotype 
but  not  the  function  of regulatory CD45RB x~  splenic T 
cells from normal mice. An obvious explanation for this is 
that  regulatory  cells  are  present  within  the  IL-10  -/- 
CD45RBI~  +  LPL population but  are ineffective be- 
cause  of their  inability to  produce  IL-10.  However,  this 
conclusion  may  be  oversimplified  when  other  data  are 
taken into consideration. For example, IL-10 treatment of 
weanling IL-10 -/-  mice prevented the induction of IBD, 
whereas  delayed  administration  of  IL-10  was  unable  to 
eliminate established disease (18).  This  finding is contrary 
to  the  concept that regulatory cells need  only to produce 
IL-10 in order to control TH1  responses. It is possible that 
IL-10 may play a  critical role in the generation of regula- 
tory  cells  which  mediate  their  control  independently  of 
their  own  production  of IL-10.  Relevant  to  this,  in  the 
CD45R.B ~ transfer model, IL-10 production by CD45RB l~ 
cells that provide protection is as low as that of CD45RB hi 
cells inducing colitis (13). 
In conclusion, we have clearly established that THl-like 
ot[~TCR§  -  and CD4+CD8oO  T  cells mediate 
IBD in IL-10  -/-  mice. As IBD in numerous murine mod- 
els  is  proposed  to  result  from  a  perturbation  of T  cell- 
dependent  regulation in  the  gut  and  a  subsequent  break- 
down  of oral  tolerance  (38,  39),  we  are  employing  the 
IL-10 -/-  and the CD45RBhiCD4 +  T  cell transfer models 
of IBD to define the regulatory circuits that ensure the in- 
tegrity of the mucosal immune response. 
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